Parexel and Eli Lilly are launching a clinical research learning and development program in China as recent reforms have “dramatically” increased the need for new sites in the country. (outsourcing-pharma.com)
Article by Teresa C. Gallagher, Ph.D., M.S. On November 13, 2018, BIOCOM’s San Diego office offered a panel presentation to its members on “Clinical Trials in the Asia Pacific Region: The Competitive Edge.” BIOCOM is a trade association and advocate for California’s life science sector, with offices in San Diego, Read more
According to a recent report, 3,458 deaths occurred and more than 14,300 people in India reported side effects in clinical trials between 2005 and 2013, but in only 89 cases was any compensation given. How can we make ethical research in India a priority? Experts argue that the solution requires a pharmacovigilance framework where regulatory bodies acquire clinical data independent of company sources.
Contributed article by Mary Nguyen, Ph.D. I hadn’t always planned to go into clinical research. As I bioengineer, I was motivated by projects that could benefit patient outcomes. Since joining Neox, I am now directly involved in delivering innovative therapies to patients awaiting life-saving treatment. I recently had the opportunity to Read more
Iranian hackers with connections to the hacking organization the Mabna Institute stole research data that cost billions of dollars to acquire from hundreds of universities, academic journals, and private companies over the past four years. The cyberattack hit 144 U.S. universities and at least 36 private companies including one biotech.
In the past 15 years, South Korea has experienced astounding growth in clinical trials due to its mix of clinical experience, infrastructure, population density, demographics, educated workforce, and a supportive government. In the past 5 years, Korea has conducted more industry-sponsored drug studies than any other Asian country, and the capital city of Seoul is now the world’s top-ranked location for trials. (Life Science Leader)
GUEST BLOG BY HILDA MWANGI, ESQ., MBA. Vice Consul- Life Sciences, Department for International Trade, British Consulate General, Los Angeles On 12 September, the UK’s Department for International Trade and Pillsbury Winthrop Shaw Pittman, LLC hosted a half-day seminar on the UK’s Clinical Research offer. The event, which attracted clinical research Read more
Less than 1% of the U.S. population uses cannabis for medical purposes on a regular basis. A key obstacle to mainstream acceptance of cannabis as medical treatment is the lack of clinical trials that demonstrate safety and efficacy of treatment outcomes. The FDA will not allow medical or health claims on cannabis products that have not been proven in clinical trials, which currently cannot be conducted on cannabis as it is considered a dangerous Schedule 1 substance. (The Jerusalem Post)
In this short film, the pros and cons of animal testing from a bioethical and biological standpoint are examined. CAGED was produced and created for a final project for Miramar College’s Journalism 202: Introduction to Mass Communications course. Enjoy!
The China Food and Drug Administration (CFDA) has withdrawn 1,184 drug registration applications following a recent yearlong government investigation into clinical trials in the country. (outsourcing-pharma.com)